291 related articles for article (PubMed ID: 23220921)
1. Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.
Abman SH; Kinsella JP; Rosenzweig EB; Krishnan U; Kulik T; Mullen M; Wessel DL; Steinhorn R; Adatia I; Hanna B; Feinstein J; Fineman J; Raj U; Humpl T;
Am J Respir Crit Care Med; 2013 Mar; 187(6):572-5. PubMed ID: 23220921
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
4. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
[TBL] [Abstract][Full Text] [Related]
5. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China].
Xiong CM; He JG; Lu XL; Shan GL; Wu BX; Zhu XY; Wu GH; Zeng XF; Guo T; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Tian HY; Li WM; Zhang DZ; Zhang C; Li MT; Liu HM; Guo YJ; Shen JY; Zhang WJ; Liu S; Zhou DX; Bao CD; Huang SA; Chen JY; Wu WF; Huang K; Li CL; Wang LH; He B
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):370-4. PubMed ID: 21418907
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
[TBL] [Abstract][Full Text] [Related]
8. [Sildenafil therapy for pulmonary hypertension: a prospective study].
Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zeng WJ; Zhu F; He JG
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):419-23. PubMed ID: 21781512
[TBL] [Abstract][Full Text] [Related]
9. Oral sildenafil therapy for Chinese patients with pulmonary arterial hypertension: a multicenter study.
Xiong CM; Lu XL; Shan GL; Wu BX; Zhu XY; Wu GH; Zeng XF; Guo T; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Tian HY; Li WM; Zhang DZ; Zhang C; Li MT; Liu HM; Guo YJ; Shen JY; Zhang WJ; Liu S; Zhou DX; Bao CD; Huang SA; Chen JY; Wu WF; Huang K; Li CL; Wang LH; He B; He JG; Li JJ
J Clin Pharmacol; 2012 Mar; 52(3):425-31. PubMed ID: 21415281
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis].
Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963
[TBL] [Abstract][Full Text] [Related]
11. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
12. Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.
Kumar U; Sankalp G; Sreenivas V; Kaur S; Misra D
Rheumatol Int; 2013 Apr; 33(4):1047-52. PubMed ID: 22833239
[TBL] [Abstract][Full Text] [Related]
13. Food and Drug Administration (FDA) postmarket reported side effects and adverse events associated with pulmonary hypertension therapy in pediatric patients.
Maxey DM; Ivy DD; Ogawa MT; Feinstein JA
Pediatr Cardiol; 2013 Oct; 34(7):1628-36. PubMed ID: 23532466
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil and pulmonary hypertension in children.
Prescrire Int; 2012 Jul; 21(129):178. PubMed ID: 22852281
[No Abstract] [Full Text] [Related]
15. Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre.
Douwes JM; Roofthooft MT; Van Loon RL; Ploegstra MJ; Bartelds B; Hillege HL; Berger RM
Heart; 2014 Feb; 100(3):224-30. PubMed ID: 24390161
[TBL] [Abstract][Full Text] [Related]
16. Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources.
Vida VL; Gaitan G; Quezada E; Barnoya J; Castañeda AR
Cardiol Young; 2007 Feb; 17(1):72-7. PubMed ID: 17184573
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.
Barst RJ; Ivy DD; Gaitan G; Szatmari A; Rudzinski A; Garcia AE; Sastry BK; Pulido T; Layton GR; Serdarevic-Pehar M; Wessel DL
Circulation; 2012 Jan; 125(2):324-34. PubMed ID: 22128226
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
19. Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children.
Nemoto S; Sasaki T; Ozawa H; Katsumata T; Kishi K; Okumura K; Mori Y; Umegaki O
Eur J Cardiothorac Surg; 2010 Jul; 38(1):71-7. PubMed ID: 20206543
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ
Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
